Skip to main content

2 Result(s)

within L Vietri Remove this filter

and

  1. No Access

    Article

    Effects of rituximab therapy on B cell differentiation and depletion

    Rituximab is a human/murine chimeric anti-CD20 monoclonal antibody. It is largely used to treat B cell malignancies and has become standard in the management of B cell‑mediated diseases such as rheumatoid arth...

    L. Bergantini, M. d’Alessandro, P. Cameli, L. Vietri, C. Vagaggini… in Clinical Rheumatology (2020)

  2. No Access

    Article

    Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies

    Asthma is an immunoinflammatory disease characterized by bronchial hyper-reactivity to different external stimuli. New monoclonal target treatments have been developed, but few studies have investigated the ro...

    L Bergantini, P Cameli, M d’Alessandro, L Vietri, M Perruzza, M Pieroni… in Inflammation (2020)